{"lead_paragraph": "The drug maker\u2019s acting C.E.O., Howard B. Schiller, said it was uncertain when J. Michael Pearson, who Valeant said had been hospitalized with severe pneumonia, would be back.", "pub_date": "2016-01-14T00:00:00Z", "slideshow_credits": null, "byline": {"person": [{"lastname": "POLLACK", "role": "reported", "rank": 1, "organization": "", "firstname": "Andrew"}], "original": "By ANDREW POLLACK"}, "document_type": "article", "section_name": "Business Day", "snippet": "The drug maker\u2019s acting C.E.O., Howard B. Schiller, said it was uncertain when J. Michael Pearson, who Valeant said had been hospitalized with severe pneumonia, would be back.", "multimedia": [{"subtype": "wide", "width": 190, "height": 126, "type": "image", "url": "images/2016/01/14/business/14valeant-web/14valeant-web-thumbWide.jpg", "legacy": {"wide": "images/2016/01/14/business/14valeant-web/14valeant-web-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}}, {"subtype": "xlarge", "width": 600, "height": 431, "type": "image", "url": "images/2016/01/14/business/14valeant-web/14valeant-web-articleLarge.jpg", "legacy": {"xlargeheight": "431", "xlarge": "images/2016/01/14/business/14valeant-web/14valeant-web-articleLarge.jpg", "xlargewidth": "600"}}, {"subtype": "thumbnail", "width": 75, "height": 75, "type": "image", "url": "images/2016/01/14/business/14valeant-web/14valeant-web-thumbStandard.jpg", "legacy": {"thumbnail": "images/2016/01/14/business/14valeant-web/14valeant-web-thumbStandard.jpg", "thumbnailheight": "75", "thumbnailwidth": "75"}}], "blog": [], "type_of_material": "News", "headline": {"main": "Ailing Valeant Chief&#8217;s Return Date Is Uncertain ", "print_headline": "Valeant Official Says Chief&#8217;s Return Date Is Uncertain "}, "keywords": [{"rank": "1", "name": "persons", "is_major": "Y", "value": "Pearson, John Michael (1959- )"}, {"rank": "2", "name": "organizations", "is_major": "Y", "value": "Valeant Pharmaceuticals International Inc"}, {"rank": "3", "name": "subject", "is_major": "N", "value": "Appointments and Executive Changes"}, {"rank": "4", "name": "subject", "is_major": "N", "value": "Drugs (Pharmaceuticals)"}, {"rank": "5", "name": "persons", "is_major": "N", "value": "Schiller, Howard B"}], "web_url": "http://www.nytimes.com/2016/01/14/business/ailing-valeant-chiefs-return-date-is-uncertain.html", "print_page": "4", "source": "The New York Times", "news_desk": "Business", "abstract": "Valeant Pharmaceuticals interim chief executive Howard B Schiller says it is unclear when J Michael Pearson will return as chief; Pearson is recovering from pneumonia.", "word_count": "475", "_id": "5696f7a038f0d865e6c34986", "subsection_name": null}